Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma

International Journal of Oncology

Volumn 13, Issue 2, 1998, Pages 289-295

  Mehle, Christer ^a   Lindblom, Annika ^b   Ljungberg, Börje ^a   Stenling, Roger ^a   Roos, Göran ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chromosome 3p; Loss of heterozygosity; Renal cell carcinoma; Telomerase

Indexed keywords

TELOMERASE;

ARTICLE; CELL IMMORTALIZATION; CHROMOSOME 3P; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REPRESSION; GENE DELETION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KARYOTYPING; KIDNEY CARCINOMA; PRIORITY JOURNAL; SENESCENCE; TUMOR SUPPRESSOR GENE;

EID: 0031847298     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.2.289     Document Type: Article

References (44)

1. Kovacs G: Molecular cytogenetics of renal cell tumors. Adv Cancer Res 62: 89-124, 1993.
2. Kovacs G: Molecular differential pathology of renal cell tumours. Histhopathology 22: 1-8, 1993.
3. Maher ER: Tumours in Urology, Biology and Clinical Management. Neald DE (ed.) Springer Verlag, London, pp225-242, 1994.
4. Sezinger BR, Klinger HP, Junien C, Nakamura Y, Le Beau M, Cavence W, Emanuel B, Ponder B, Naylor S, Mitelman F, Louis D, Menon A, Newsham I, Decker J, Kaelbling M, Henry I and von Deimling A: Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet 58: 1080-1096, 1991.
5. Zbar B, Brauch H, Talmadge C and Linehan M: Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 327: 721-724, 1987.
6. Bergerheim U, Nordenskjöld M and Collins VP: Deletion mapping in human renal cell carcinoma. Cancer Res 49: 1390-1396, 1989.
7. Yamakawa K, Morita R, Takahashi E, Hori T, Ishikawa J and Nakamura Y: A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. Cancer Res 51: 4707-4711, 1991.
8. Anglard P, Tory K, Brauch H, Weiss GH, Latif F, Merino MJ, Lerman MI, Zbar B and Linehan WM: Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res 51: 1071-1077, 1991.
9. Van der Hout AH, van den Berg E, van der Vlies P, Dijkhuizen T, Störkel S, Oosterhuis JW, De Jong B and Buys CHCM: Loss of heterozygosity at the short arm of chromosome 3 in renal-cell cancer correlates with the cytological tumour type. Int J Cancer 53: 353-357, 1993.
10. Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MMF, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, Buys CHCM and Maher ER: Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in nonfamilial clear cell renal carcinoma. Hum Mol Genet 3: 2169-2173, 1994.
11. Hadaczek P, Podolski J, Toloczko A, Kurazawski G, Sikorski A, Rabbitts P, Huebner K and Lubinski J: Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations. Virchows Arch 429: 37-42, 1996.
12. Erlandsson R, Boldog F, Persson B, Zabarovsky ER, Allikmets RL, Sumegi J, Klein G and Jörnvall H: The gene from the short arm of chromosome 3, at D3F15S2, frequently deleted in renal cell carcinoma, encodes acylpeptide hydrolase. Oncogene 6: 1293-1295, 1991.
13. La Forgia S, Morse B, Levy J, Barnea G, Cannizzaro LA, Li F, Nowell PC, Boghosian-Sell L, Glick J, Weston A, et al: Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. Proc Natl Acad Sci US A 88: 5036-5040, 1991.
14. Lindblom A, Tannergård P, Werelius B and Nordenskjöld M: Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 5: 279-282, 1993.
15. Boldog FL, Gemmill RM, Wilke CM, Glover TW, Nilsson AS, Chandrasekharappa SC, Brown RS, Li FP and Drabkin HA: Positional cloning of the hereditary renal carcinoma 3;8 chromosome translocation breakpoint. Proc Natl Acad Sci USA 90: 8509-8513, 1993.
16. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, et al: Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7: 85-90, 1994.
17. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman M and Yao M: Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54: 2852-2855, 1994.
18. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW and Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114-10118, 1992.
19. Allsopp RC and Harley CB: Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219: 130-136, 1995.
20. Greider CW and Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413, 1985.
21. Morin GB: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529, 1989.
22. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
23. Wright WE and Shay JW: The two-stage mechanism controlling cellular senescence and immortalization. Exp Geronontol 27: 383-389, 1992.
24. Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14:4240-4248, 1995.
25. Mehle C, Piatyszek MA, Ljungberg B, Shay JW and Roos G: Telomerase activity in human renal cell carcinoma. Oncogene 13: 161-166, 1996.
26. Fiedler W, Dahse R, Schlichter A, Junker K, Kosmehl H, Ernst G, Schubert J and Clausen U: Telomerase activity and telomere length in different areas of renal cell carcinoma. Int J Oncol 9: 1227-1232, 1996.
27. Pereira-Smith OM and Smith JR: Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc Natl Acad Sci USA 85:6042-6046, 1988.
28. Barrett JC, Annab LA, Alcarta D, Preston G, Vojta P and Yin Y: Cellular senescence and cancer. Cold Spring Harb Symp Quant Biol 59: 411-418, 1994.
29. Rimessi P, Gualandi F, Morelli C, Trabanelli C, Wu Q, Possati L, Montesi M, Barret JC and Barbaranti-Brodano G: Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer. Oncogene 9: 3467-3474, 1994.
30. Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, Yoshida MA, Tahara E, Shay JW, Barrett C and Oshimura M: Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 86: 899-904, 1995.
31. Weiss LM, Gelb AB and Medeiros LJ: Adult renal epithelial neoplasms. Am J Clin Pathol 103: 624-635, 1994.
32. Mehle C, Ljungberg B and Roos G: Telomere shortening in renal cell carcinoma. Cancer Res 54: 236-241, 1994.
33. Gemmill RM, Chumakov I, Scott P, Waggoner B, Rigault P, Cypser P, Chen Q, Weissenbach J, Gardiner K, Wang H, Pekarsky Y, Le Gall I, Le Paslier D, Guillou S, Li E, Robinson L, Hahner L, Todd S, Cohen D and Drabkin HA: A second-generation YAC contig map of human chromosome 3. Nature 377: 299-319, 1995.
34. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE and Shay JW: Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 17: 1-5, 1995.
35. Wilhelm M, Bugert P, Kenck C, Staehler G and Kovacs G: Terminal deletion of chromosome 3p sequences in non-papillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603. Cancer Res 55: 5383-5385, 1995.
36. Bugert P, Kenck C, Wilhelm M and Kovacs G: Refining a proximal breakpoint cluster at chromosome 3p11.2 in non-papillary renal cell carcinomas. Int J Cancer 68: 723-726, 1996.
37. Hughson MD, Meloni A, Dougherty S, Silva FG and Sandberg A: Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas. Correlation with tumor karyotypes. Cancer Genet Cytogenet 87: 133-139, 1996.
38. Presti JC, Reuter VE, Cordon-Cardo C, Mazumdar M, Fair WR and Jhanwar SC: Allelic deletions in renal tumors: histopathological correlations. Cancer Res 53: 5780-5783, 1993.
39. Uzawa N, Yoshida MA, Oshimura M and Ikeuchi T: Suppression of tumorigenicity in three different cell lines of human oral squamous cell carcinoma by introduction of chromosome 3p via microcell-mediated chromosome transfer. Oncogene 11: 1997-2004, 1995.
40. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M, Huebner K and Croce CM: The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 85: 17-26, 1996.
41. Todd MC, Xiang R-H, Garcia DK, Kerbacher KE, Moore SL, Hensel CH, Liu P, Siciliano MJ, Kok K, van den Berg A, Veldhuis P, Buys CHCM, Killary AM and Naylor S: An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. Oncogene 13: 2387-2396, 1996.
42. Dahse R, Fiedler W, Ernst G Kosmehl H, Schlichter A, Schubert J and Clausen U: Changes in telomere lengths in renal cell carcinomas. Cell Mol Biol 42: 477-485, 1996.
43. Uchida T, Wada C, Shitara T, Egawa S, Mashimo S and Koshiba K: Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma. J Ural 159: 1298-1301, 1993.
44. Walther MM, Gnarra JR, Elwood L, Xu HJ, Florence C, Anglard P, Hu SX, King C, Trahan E, Hurley K, Sens D, Venzon D, Liu S, Jaffe GS, Benedict W, Fand W and Linehan WM: Loss of heterozygosity occurs centromeric to RB without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma. J Urol 153: 2050-2054, 1995.